Edition:
United States

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

7.04CNY
20 Jan 2017
Change (% chg)

¥0.05 (+0.72%)
Prev Close
¥6.99
Open
¥6.99
Day's High
¥7.07
Day's Low
¥6.99
Volume
5,414,859
Avg. Vol
15,016,955
52-wk High
¥7.90
52-wk Low
¥6.00

600572.SS

Chart for 600572.SS

About

Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company engaged in the research, development, production and sale of traditional Chinese medicines, herbal medicines, chemical drugs, bulk drugs and healthcare products. The Company's main products consist of Qianliekang branded tablets and capsules for the treatment of... (more)

Overall

Beta: 0.92
Market Cap(Mil.): ¥17,650.43
Shares Outstanding(Mil.): 2,510.73
Dividend: 0.07
Yield (%): 0.95

Financials

  600572.SS Industry Sector
P/E (TTM): 64.11 29.51 30.38
EPS (TTM): 0.11 -- --
ROI: 4.68 15.44 14.86
ROE: 6.14 16.62 16.28

BRIEF-Zhejiang CONBA Pharmaceutical unit gets nod for clinic trial

* Says its unit gets China Food and Drug Administration's approval for clinic trial of a drug for preventing thrombus of atherosclerosis and acute coronary artery syndrome

Nov 07 2016

BRIEF-Zhejiang Conba Pharma's 9-month net profit down 26.8 pct

Further company coverage: (Reporting by Hong Kong newsroom)

Oct 27 2016

BRIEF-Zhejiang Conba Pharmaceutical issues 1.1 bln yuan 5-YR bonds

* Says it issues 1.1 billion yuan worth bonds, with coupon rate at 3.17 percent

Oct 21 2016

BRIEF-Zhejiang Conba Pharmaceutical to issue 1.1 bln yuan 5-yr bonds

* Says to issue 1.1 billion yuan ($164.89 million) 5-year bonds

Sep 21 2016

BRIEF-Zhejiang Conba Pharmaceutical unit gets clinical trial approval for Anidulafungin Anidulafungin for injection

* Says its subsidiary Jinhua Kang'enbei Biology Pharmacy got clinical trial approval for Anidulafungin Anidulafungin for injection

Sep 16 2016

BRIEF-Zhejiang CONBA Pharmaceutical to fully acquire Inner Mongolia unit for 50 mln yuan

* Says it will acquire 12 percent stake in its Inner Mongolia pharmaceutical unit for 50 million yuan

Aug 24 2016

BRIEF-Zhejiang Conba Pharmaceutical unit gets nod for clinic trial

Aug 12 Zhejiang Conba Pharmaceutical Co., Ltd. :

Aug 11 2016

BRIEF-Zhejiang Conba Pharma to invest further in online health service firm

* Says it plans to invest 146 million yuan ($21.96 million) in online health service firm for another 8 percent stake, bringing its holdings to 20 percent

Jul 29 2016

Earnings vs. Estimates